Research Article

Stomach cancer: epidemiological, diagnostic and therapeutic aspects at the Kara Teaching Hospital, Togo

DOSSOUVI Tamegnon*, EL-HADJI YAKOUBOU Rafiou, ADABRA Komlan, AMAVI Ayi, AMOUZOU Efoé-Ga Olivier, KANASSOUA Kokou Kouliwa, KASSEGNE Iroukora and DOSSEH Ekoué David

Published: 16 March, 2022 | Volume 6 - Issue 1 | Pages: 001-003

Objective: To report our experience in the management of gastric cancers at the Kara University Hospital (Togo).
Materials and methods: This was a retrospective and prospective study which was conducted from January 1, 2018, to July 31, 2021, in the general surgery and hepato-gastroenterology department of the Kara University Hospital (Togo). This study involved all patients treated for gastric cancer during the study period at CHU Kara (Togo).
Results: We recorded 32 gastric cancers out of the 218 cases of cancer diagnosed during the study period. We had 20 men and 12 women with a sex ratio (M/F = 1.7). The average age was 58 years with the extremes ranging from 17 to 85 years. The pattern of the consultation was dominated by epigastralgia (100%) and deterioration in general condition (100%). Upper digestive endoscopy with biopsies was performed in all our patients. The antral localization was the most found in 62.5% of cases. The most common macroscopic appearance was ulcers-budding (90.6%) and the dominant histological type was moderately differentiated adenocarcinoma (87.5%). The extension assessment found liver metastasis in 10 cases, multiple regional lymphadenopathies of the hepatic pedicle and celiac trunk in 26 cases, ascites related to peritoneal carcinomatosis in 26 cases. Therapeutically, a 4/5 gastrectomy with D1 dissection was performed in 6 cases; gastrojejunal anastomosis in one case and palliative treatment in 25 cases. Survival at 1 year is 50% (3 patients) among operated patients. All the other patients (78.1%) who received palliative treatment all died within 3 months.
Conclusion: Improving the prognosis of stomach cancer like other cancers requires early diagnosis to perform a gastrectomy, the only guarantee of long survival.

Read Full Article HTML DOI: 10.29328/journal.ascr.1001062 Cite this Article Read Full Article PDF


Stomach cancer; Diagnostic delay; Gastrectomy; Chemotherapy


  1. Les cancers en Afrique francophone. La Ligue
    Nationale contrele Cancer (France). 2017.
  2. Chapelle N, Manfredi S, Lepage C, Faivre J, Bouvier AM, et al. Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population. Gastric Cancer. 2016; 19: 508–514. PubMed: https://pubmed.ncbi.nlm.nih.gov/26118904/
  3. Rokkas T. A qyqtematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol. 2017; 30: 414-423. PubMed: https://pubmed.ncbi.nlm.nih.gov/28655977/
  4. Dossouvi T, Yakoubou RE, Bouglouga O, Kanassoua KK, Kassegne I, et al.Profil epidemiologique des cancers digestifs au chu-kara (Togo).J Afr Chir Digest. 2021; 21: 3464-3468.
  5. Asombang AW, Kelly P. Gastric cancer in Africa: what do we know about incidence and risk factors?
    Trans R Soc Trop Med Hyg. 2012; 106: 69-74. PubMed: https://pubmed.ncbi.nlm.nih.gov/22136952/
  6. Wong BC, Lam SK, Ching CK, Hu WH, Kwok E, et al.
    Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk
    regions of South China. J Gastroenterol Hepatol. 1999; 14: 120–125. PubMed: https://pubmed.ncbi.nlm.nih.gov/10029291/
  7. Fadlouallah M, Krami H, Errabih I, Benzzoubeir N, et al. Le cancer gastrique : aspects épidémiologiques au Maroc. J. Afr. Cancer. 2014; 1-7.
  8. Diarra MT, Konaté A, Diarra AN, Sow HEC, Doumbia KES, et al. Epidemiological characteristics and prognosis of gastric Cancer in urban areas of Mali. Mali Med. 2014; 29: 50-54. PubMed: https://pubmed.ncbi.nlm.nih.gov/30049116/
  9. Bouglouga O, Lawson-Ananissoh LM, Bagny A, Kaaga L, Amegbor K. Stomach cancer: Epidemiological, clinical and histological aspects at the Lome Campus teaching hospital
    (Togo). Med Sante Trop. 2015; 25: 65-85. PubMed: https://pubmed.ncbi.nlm.nih.gov/25786857/
  10. Diop B, Dia AA, Ba PA, Sow O, Thiam O, et al. Prise en charge chirurrgicale des tumeurs gastriques à Dakar: à propos de 36 observations. Health Sci. Dis. 2017; 18: 34-38.
  11. Bouglouga O, Bagny A, Lawson-Ananissoh LM, Djibril MA, Redah D, et al. La prise en charge du carcinome hépatocellulaire progresse-t-elle en Afrique noire? Rev Med Adag. 2012; 2: 176-179.
  12. Russo AE, Strong VE. Gastric Cancer Etiology and Management in Asia and the West. Ann Rev Med. 2018; 70: 353–367.

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More